Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,295.90 -43.16 (-3.22%)
Heron Therapeutics, Inc. (HRTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 12:24PM EDT. Market open.
| Previous close | 2.5000 |
| Open | 2.4600 |
| Bid | 2.3200 x 800 |
| Ask | 2.3500 x 200 |
| Day's range | 2.3300 - 2.4600 |
| 52-week range | 0.5000 - 3.2200 |
| Volume | |
| Avg. volume | 2,240,548 |
| Market cap | 352.522M |
| Beta (5Y monthly) | 1.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Heron Therapeutics...
- Simply Wall St.
Heron Therapeutics Full Year 2023 Earnings: Beats Expectations
Heron Therapeutics ( NASDAQ:HRTX ) Full Year 2023 Results Key Financial Results Revenue: US$127.0m (up 18% from FY...
© 2024 Yahoo. All rights reserved.